171 related articles for article (PubMed ID: 22531957)
21. Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry.
Daan NM; Schweitzer KJ; van der Vaart CH
Int Urogynecol J; 2012 Nov; 23(11):1619-24. PubMed ID: 22543547
[TBL] [Abstract][Full Text] [Related]
22. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
Choe JH; Choo MS; Lee KS
J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
[TBL] [Abstract][Full Text] [Related]
23. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.
Haab F
Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S2-5. PubMed ID: 25042138
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care.
Odeyemi IA; Dakin HA; O'Donnell RA; Warner J; Jacobs A; Dasgupta P
Int J Clin Pract; 2006 Aug; 60(8):949-58. PubMed ID: 16893437
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study. Comment.
Dökmeci F; Cetinkaya SE
Int Urogynecol J; 2013 May; 24(5):885. PubMed ID: 23572087
[No Abstract] [Full Text] [Related]
26. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
Nitti VW; Rovner ES; Bavendam T
BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
[TBL] [Abstract][Full Text] [Related]
27. Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
Chancellor MB; Yehoshua A; Waweru C; Globe D; Cheng IN; Campbell KL; Joshi M; Pulicharam R
Int Urol Nephrol; 2016 Jul; 48(7):1029-36. PubMed ID: 27032397
[TBL] [Abstract][Full Text] [Related]
28. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
29. Is there any association between urodynamic variables and severity of overactive bladder in women with idiopathic detrusor overactivity?
Giarenis I; Zacchè M; Robinson D; Cardozo L
Neurourol Urodyn; 2017 Mar; 36(3):780-783. PubMed ID: 27092808
[TBL] [Abstract][Full Text] [Related]
30. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
[TBL] [Abstract][Full Text] [Related]
31. Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics.
Cho KJ; Kim HS; Koh JS; Kim JC
Int Urogynecol J; 2013 Feb; 24(2):325-30. PubMed ID: 22717785
[TBL] [Abstract][Full Text] [Related]
32. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity.
Guralnick ML; Grimsby G; Liss M; Szabo A; O'Connor RC
Int Urogynecol J; 2010 Mar; 21(3):325-9. PubMed ID: 19907912
[TBL] [Abstract][Full Text] [Related]
33. Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery.
Liang CC; Hsieh WC; Huang L
Int Urogynecol J; 2017 Apr; 28(4):605-611. PubMed ID: 27678141
[TBL] [Abstract][Full Text] [Related]
34. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
35. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
[TBL] [Abstract][Full Text] [Related]
36. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
Geller EJ; Crane AK; Wells EC; Robinson BL; Jannelli ML; Khandelwal CM; Connolly A; Parnell BA; Matthews CA; Dumond JB; Busby-Whitehead J
Clin Drug Investig; 2012 Oct; 32(10):697-705. PubMed ID: 22873491
[TBL] [Abstract][Full Text] [Related]
37. The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women.
Garnett S; Swithinbank L; Ellis-Jones J; Abrams P
BJU Int; 2009 Oct; 104(7):948-53. PubMed ID: 19389015
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction.
Cho KJ; Kim HS; Koh JS; Kim JC
Int Braz J Urol; 2015; 41(4):722-8. PubMed ID: 26401865
[TBL] [Abstract][Full Text] [Related]
39. A prospective randomized trial comparing the use of tolterodine or weighted vaginal cones in women with overactive bladder syndrome.
Yüce T; Dökmeci F; Çetinkaya ŞE
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():91-7. PubMed ID: 26720597
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
